Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC
about
Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLETEfflux-mediated drug resistance in bacteria: an updateRND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibitionIdentification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003Elucidation of the RamA regulon in Klebsiella pneumoniae reveals a role in LPS regulationEfflux pump, the masked side of beta-lactam resistance in Klebsiella pneumoniae clinical isolatesRamA, a member of the AraC/XylS family, influences both virulence and efflux in Salmonella enterica serovar Typhimurium.The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium.Efflux pumps as antimicrobial resistance mechanisms.Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaThe TolC homologue of Brucella suis is involved in resistance to antimicrobial compounds and virulence.Reduction of cellular stress by TolC-dependent efflux pumps in Escherichia coli indicated by BaeSR and CpxARP activation of spy in efflux mutants.Effect of Antimicrobial Exposure on AcrAB Expression in Salmonella enterica Subspecies enterica Serovar Choleraesuis.Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.Structure, Function and Regulation of Outer Membrane Proteins Involved in Drug Transport in Enterobactericeae: the OmpF/C - TolC CaseDrug efflux pump deficiency and drug target resistance masking in growing bacteriaUsing In Vitro Dynamic Models To Evaluate Fluoroquinolone Activity against Emergence of Resistant Salmonella enterica Serovar Typhimurium.Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.Efflux pump induction by quaternary ammonium compounds and fluoroquinolone resistance in bacteria.Multidrug Efflux Systems in Microaerobic and Anaerobic BacteriaWill antimicrobial resistance of BRD pathogens impact BRD management in the future?ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar TyphimuriumPhenotypic and proteomic characterization of multiply antibiotic-resistant variants of Salmonella enterica serovar Typhimurium selected following exposure to disinfectants.The Global Regulatory Cyclic AMP Receptor Protein (CRP) Controls Multifactorial Fluoroquinolone Susceptibility in Salmonella enterica Serovar Typhimurium.Relationship of Triamine-Biocide Tolerance of Salmonella enterica Serovar Senftenberg to Antimicrobial Susceptibility, Serum Resistance and Outer Membrane Proteins.Macrolide resistance in Legionella pneumophila: the role of LpeAB efflux pump.Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems.The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host.Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli.Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump.Influence of tetracycline resistance on the transport of manure-derived Escherichia coli in saturated porous media.The TCA cycle is not required for selection or survival of multidrug-resistant Salmonella.The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB.Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli.Erythromycin resistance by L4/L22 mutations and resistance masking by drug efflux pump deficiency.Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification.
P2860
Q21133536-5B7A84A1-D681-4CB1-A956-5444F74D20FEQ24609407-32BE0D0D-2728-4ECE-AC8A-8663130C3E43Q26827930-28E7FAFC-2F96-44AE-AA83-665BFA27C739Q28473596-AC95B6A4-98C0-4925-A844-F48807484973Q28543147-41420B87-A089-4843-BA27-FE942E987A95Q33417253-72307A11-0576-4B22-8269-A95B5B3A1A7CQ33705128-B411B24F-E34F-45F2-AE8E-97F5F219805DQ33999695-5BB73F17-0422-44F7-84F2-5A3CCD12F7F6Q34003782-D5A9D925-6E27-45FF-855D-BDEBA6A2367AQ34647294-F0A32558-9A33-4174-8380-3E22469C4C0BQ35689043-BEE5533E-5A82-4D96-A634-4BD5A6169631Q36606907-FB8B8DA2-83FB-4746-B069-1A118DF1AF13Q36682191-B7942337-C03B-4455-BD4D-1F9C483C6273Q36710571-D1BE8E53-8B3F-414C-A9EC-384685DFD018Q36743082-F4B4E12E-EB00-4B78-8284-9869105D096DQ37208522-E64C1756-AE73-4E87-A299-16D7EE9373F1Q37613055-844038B1-E492-4376-9E6E-57AE9F77AFF4Q37894832-F5EB63CB-E64E-4832-9E6E-C4339C25241EQ38269145-57977703-A12B-4563-BAEA-39CCEACE03F1Q38671076-54F51969-E81A-410C-8DE9-C8919B18E132Q38792833-73F4A106-D038-40E7-A2CB-BED4A042F03AQ39096063-40264F85-5E5A-49D9-8745-44A1A13B2092Q39686150-0FD6A565-8CB7-4F8A-8725-F2F7505D7F93Q40034880-F832899A-BD5E-4430-BF3B-601CC3DE8A2CQ40065944-28030622-798B-478A-8DD9-459999B50519Q40139895-C04D5AFC-C94A-470B-ADF7-ACC7A8E40AFEQ40352718-AD8E80FB-4F0B-4F65-83D5-38195B4A3124Q40766720-1A58F5E2-EECA-4ABE-8BD9-9AB139FC39E3Q41363141-2728AA67-9231-4079-BEDB-ABDA61353E6BQ41788804-73477507-5CE6-4F98-A83E-F0CC81DEF77AQ41810482-1E698CC6-995D-4561-A531-2BA4DFCD811BQ42577017-0021E129-CCA4-4C94-B207-FD09F4CB5C5EQ42584713-01DA1C21-5CBE-4FCB-BD5E-F190164C5367Q42776660-E19B8042-74C7-4299-8BC9-CD9FD5F922A2Q43014021-EC9F275C-5709-402B-9D7E-57718B596CD7Q43098014-B4D6A0AD-E1DE-414E-9346-F7F579868CACQ43149064-3EBF238F-FFF4-494D-8323-CA2D5A96E864Q43169881-EA7237F0-2652-4B4A-A861-7C2A8B842107Q43190151-F53D07FB-7324-4973-A52F-2724B7585A8FQ43275698-645E6ACB-110F-4E11-AE26-318A09525BA8
P2860
Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Ciprofloxacin-resistant Salmon ...... n the absence of AcrB and TolC
@en
Ciprofloxacin-resistant Salmon ...... n the absence of AcrB and TolC
@en-gb
type
label
Ciprofloxacin-resistant Salmon ...... n the absence of AcrB and TolC
@en
Ciprofloxacin-resistant Salmon ...... n the absence of AcrB and TolC
@en-gb
prefLabel
Ciprofloxacin-resistant Salmon ...... n the absence of AcrB and TolC
@en
Ciprofloxacin-resistant Salmon ...... n the absence of AcrB and TolC
@en-gb
P2860
P1476
Ciprofloxacin-resistant Salmon ...... n the absence of AcrB and TolC
@en
P2093
Laura J V Piddock
Peter Tzakas
P2860
P356
10.1128/AAC.50.1.38-42.2006
P407
P577
2006-01-01T00:00:00Z